| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fe816127573d557d8bd41db832b5a20 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2014-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a90a51e8f99237714d03bb61d892e609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf318f1781982a08df7bded405faafb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70905087c3d76373b83a2ee84bc44a3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365841d94780151eeb8b9b2dc42e105d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e3522723e9aee54d46ac9523cf8c038 |
| publicationDate |
2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016263197-A1 |
| titleOfInvention |
HPYY(1-36) Having a Beta-Homoarginine Substitution at Position 35 |
| abstract |
The invention relates to PYY compounds having the amino acid in the position corresponding to position 35 of hPYY(1-36) substituted with beta-homoarginine and derivatives thereof with a modifying group attached to the position corresponding to position 7 of hPYY(1-36). The compounds of the invention are selective Y2 receptor agonists. The invention also relates to pharmaceutical compositions comprising such PYY compounds and pharmaceutically acceptable excipients, as well as the medical use of the PYY compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11744873-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246497-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021228679-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11382957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759501-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759502-B2 |
| priorityDate |
2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |